{
    "eid": "2-s2.0-85125612950",
    "title": "Cell-penetrating peptides containing the progesterone receptor polyproline domain inhibits EGF signaling and cell proliferation in lung cancer cells",
    "cover-date": "2022-03-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Multidisciplinary",
            "@code": "1000",
            "@abbrev": "MULT"
        }
    ],
    "keywords": [],
    "authors": [
        "Panthita Kaewjanthong",
        "Sarintip Sooksai",
        "Hironobu Sasano",
        "Gyorgy Hutvagner",
        "Sarah Bajan",
        "Eileen McGowan",
        "Viroj Boonyaratanakornkit"
    ],
    "citedby-count": 5,
    "ref-count": 86,
    "ref-list": [
        "Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries",
        "Non-small cell lung cancer: Epidemiology, risk factors, treatment, and survivorship",
        "Understanding and targeting resistance mechanisms in NSCLC",
        "Drug resistance to targeted therapeutic strategies in non-small cell lung cancer",
        "Combination of EGFR-TKIs and chemotherapy in advanced EGFR mutated NSCLC: Review of the literature and future perspectives",
        "Emerging therapeutic agents for advanced non-small cell lung cancer",
        "The emerging treatment landscape of targeted therapy in non-small-cell lung cancer",
        "Epidermal growth factor receptor: Mechanisms of activation and signalling",
        "Epidermal growth factor receptor in non-small-cell lung carcinomas: Correlation between gene copy number and protein expression and impact on prognosis",
        "Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer",
        "Phosphorylation, but not overexpression, of epidermal growth factor receptor is associated with poor prognosis of non-small cell lung cancer patients",
        "Blockade of receptors for growth factors: An anticancer therapy-the fourth annual Joseph H Burchenal American Association of Cancer Research Clinical Research Award Lecture",
        "Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: A randomized trial",
        "The prognostic role of EGFR-TKIs for patients with advanced non-small cell lung cancer",
        "Cell signaling by receptor tyrosine kinases",
        "Epidermal growth factor receptor dimerization and activation require ligand-induced conformational changes in the dimer interface",
        "SH2 and SH3 domains",
        "The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1",
        "Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases",
        "Progesterone receptor interacting coregulatory proteins and cross talk with cell signaling pathways",
        "The role of extranuclear signaling actions of progesterone receptor in mediating progesterone regulation of gene expression and the cell cycle",
        "The role and mechanism of progesterone receptor activation of extra-nuclear signaling pathways in regulating gene transcription and cell cycle progression",
        "Progesterone receptor in non-small cell lung cancer-a potent prognostic factor and possible target for endocrine therapy",
        "Progesterone receptor (PR) polyproline domain (PPD) mediates inhibition of epidermal growth factor receptor (EGFR) signaling in non-small cell lung cancer cells",
        "Cell-Penetrating Peptides: Possibilities and Challenges for Drug Delivery in Vitro and in Vivo",
        "Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231",
        "Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide",
        "Solid formulation of cellpenetrating peptide nanocomplexes with siRNA and their stability in simulated gastric conditions",
        "Mechanism of anticancer activity of buforin IIb, a histone H2A-derived peptide",
        "New opportunities by synthetic biology for biopharmaceutical production in Pichia pastoris",
        "Pichia pastoris: A highly successful expression system for optimal synthesis of heterologous proteins",
        "Protein expression in Pichia pastoris: Recent achievements and perspectives for heterologous protein production",
        "An activation of LC3A-mediated autophagy contributes to de novo and acquired resistance to EGFR tyrosine kinase inhibitors in lung adenocarcinoma",
        "SH3 domains: Modules of protein-protein interactions",
        "Specificity and versatility of SH3 and other proline-recognition domains: Structural basis and implications for cellular signal transduction",
        "A cancer specific cell-penetrating peptide, BR2, for the efficient delivery of an scFv into cancer cells",
        "Enhancement of the cancer targeting specificity of buforin IIb by fusion with an anionic peptide via a matrix metalloproteinases-cleavable linker",
        "MAP kinase signalling pathways in cancer",
        "ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours",
        "Cyclin D1 in non-small cell lung cancer: A key driver of malignant transformation",
        "A two kinase-gene signature model using CDK2 and PAK4 expression predicts poor outcome in non-small cell lung cancers",
        "Activating and resistance mutations of EGFR in non-small-cell lung cancer: Role in clinical response to EGFR tyrosine kinase inhibitors",
        "EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy",
        "The Significance of MMP-1 in EGFRTKI-Resistant Lung Adenocarcinoma: Potential for Therapeutic Targeting",
        "Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection",
        "Less Toxic Chemotherapy Improves Uptake of All Lines of Chemotherapy in Advanced Non-Small-Cell Lung Cancer A 10-Year Retrospective Population-Based Review",
        "Hormonal carcinogenesis",
        "Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B",
        "Differential quantitative proteomics reveals key proteins related to phenotypic changes of breast cancer cells expressing progesterone receptor A",
        "Nuclear receptor expression defines a set of prognostic biomarkers for lung cancer",
        "The prognostic role of progesterone receptor expression in non-small cell lung cancer patients: Gender-related impacts and correlation with disease-specific survival",
        "Progesterone and estrogen receptor expression and activity in human non-small cell lung cancer",
        "Combined analysis of estrogen receptor beta-1 and progesterone receptor expression identifies lung cancer patients with poor outcome",
        "Immunohistochemical expression of estrogen and progesterone receptors identifies a subset of NSCLCs and correlates with EGFR mutation",
        "A Sos-derived peptidimer blocks the Ras signaling pathway by binding both Grb2 SH3 domains and displays antiproliferative activity",
        "Grb2 Sh3 Binding to Peptides from Sos-Evaluation of a General-Model for Sh3-Ligand Interactions",
        "Grb2-SH3 ligand inhibits the growth of HER2(+) cancer cells and has antitumor effects in human cancer xenografts alone and in combination with docetaxel",
        "Creation of novel cell-penetrating peptides for intracellular drug delivery using systematic phage display technology originated from tat transduction domain",
        "Caveolae-mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time",
        "Liposomes equipped with cell penetrating peptide BR2 enhances chemotherapeutic effects of cantharidin against hepatocellular carcinoma",
        "Expression of heterologous proteins in Pichia pastoris: A useful experimental tool in protein engineering and production",
        "Detection of N-glycolyated gangliosides in non-small-cell lung cancer using GMR8 monoclonal antibody",
        "Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy",
        "Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): An open label, randomised phase 3 trial",
        "Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR",
        "The Efficacy of Single-Agent Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy in Biologically Selected Patients with Non-Small-Cell Lung Cancer: A Meta-Analysis of 19 Randomized Controlled Trials",
        "Impact of EGFR Inhibitor in Non-Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis",
        "Efficacy of epidermal growth factor receptor inhibitors versus chemotherapy as second-line treatment in advanced non-small-cell lung cancer with wild-type EGFR: A meta-analysis of randomized controlled clinical trials",
        "Structures of lung cancer-derived EGFR mutants and inhibitor complexes: Mechanism of activation and insights into differential inhibitor sensitivity",
        "Cyclin-dependent kinase inhibitors for the treatment of lung cancer",
        "Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib",
        "Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor-mutant lung adenocarcinomas with acquired resistance to kinase inhibitors",
        "EGFR mutation and resistance of non-small-cell lung cancer to gefitinib",
        "Analysis of epidermal growth factor receptor gene mutation in patients with non-small cell lung cancer and acquired resistance to gefitinib",
        "Mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer",
        "Sensitivity to gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines correlates with dependence on the epidermal growth factor (EGF) receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt pathway for proliferation",
        "Overcoming drug resistance to receptor tyrosine kinase inhibitors: Learning from lung cancer",
        "Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR-Mutant Lung Cancers",
        "Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors",
        "Mechanisms of acquired resistance to EGFR-tyrosine kinase inhibitor in Korean patients with lung cancer",
        "MET Oncogene in Non-Small Cell Lung Cancer: Mechanism of MET Dysregulation and Agents Targeting the HGF/c-Met Axis",
        "Met Activation in Non-Small Cell Lung Cancer Is Associated with de Novo Resistance to EGFR Inhibitors and the Development of Brain Metastasis",
        "MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling",
        "Apatinib preferentially inhibits PC9 gefitinib-resistant cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway",
        "MEK inhibitors reverse resistance in epidermal growth factor receptor mutation lung cancer cells with acquired resistance to gefitinib"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Sydney",
            "@id": "60023932",
            "affilname": "University of Technology Sydney",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023932",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Sendai",
            "@id": "60180317",
            "affilname": "Graduate School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60180317",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Birtinya",
            "@id": "60159369",
            "affilname": "Sunshine Coast Health Institute",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60159369",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Sippy Downs",
            "@id": "60032607",
            "affilname": "University of the Sunshine Coast",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032607",
            "affiliation-country": "Australia"
        }
    ],
    "funding": []
}